Literature DB >> 19559158

Osteoporosis in inflammatory bowel disease.

Tauseef Ali1, David Lam, Michael S Bronze, Mary Beth Humphrey.   

Abstract

Osteoporosis commonly afflicts patients with inflammatory bowel disease, and many factors link the 2 states together. A literature review was conducted about the pathophysiology of osteoporosis in relation to inflammatory bowel disease. Screening guidelines for osteoporosis in general as well as those directed at patients with inflammatory bowel disease are reviewed, as are currently available treatment options. The purpose of this article is to increase physician awareness about osteopenia and osteoporosis occurring in patients with inflammatory bowel disease and to provide basic, clinically relevant information about the pathophysiology and guidelines to help them treat these patients in a cost-effective manner.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19559158      PMCID: PMC2894700          DOI: 10.1016/j.amjmed.2009.01.022

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  46 in total

Review 1.  AGA technical review on osteoporosis in gastrointestinal diseases.

Authors:  Charles N Bernstein; William D Leslie; Meryl S Leboff
Journal:  Gastroenterology       Date:  2003-03       Impact factor: 22.682

2.  Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease.

Authors:  N Franchimont; V Putzeys; J Collette; S Vermeire; P Rutgeerts; M De Vos; A Van Gossum; D Franchimont; R Fiasse; P Pelckmans; M Malaise; J Belaiche; E Louis
Journal:  Aliment Pharmacol Ther       Date:  2004-09-15       Impact factor: 8.171

3.  Calcitonin in the prevention and treatment of osteoporosis.

Authors:  C H Chestnut
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

Review 4.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1994

5.  Osteoclasts are essential for TNF-alpha-mediated joint destruction.

Authors:  Kurt Redlich; Silvia Hayer; Romeo Ricci; Jean-Pierre David; Makiyeh Tohidast-Akrad; George Kollias; Günter Steiner; Josef S Smolen; Erwin F Wagner; Georg Schett
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

Review 6.  The pathophysiology of bone disease in gastrointestinal disease.

Authors:  Charles N Bernstein; William D Leslie
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-08       Impact factor: 2.566

7.  Effect of antitumour necrosis factor-alpha therapy on bone turnover in patients with active Crohn's disease: a prospective study.

Authors:  B M Ryan; M G V M Russel; L Schurgers; M Wichers; J Sijbrandij; R W Stockbrugger; E Schoon
Journal:  Aliment Pharmacol Ther       Date:  2004-10-15       Impact factor: 8.171

8.  Osteoporosis in patients with inflammatory bowel disease.

Authors:  J E Compston; D Judd; E O Crawley; W D Evans; C Evans; H A Church; E M Reid; J Rhodes
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

9.  Bone density improves with disease remission in patients with inflammatory bowel disease.

Authors:  David M Reffitt; John Meenan; Jeremy D Sanderson; Ravin Jugdaohsingh; Jonathan J Powell; Richard P Thompson
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-12       Impact factor: 2.566

10.  Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study.

Authors:  P Szulc; M C Chapuy; P J Meunier; P D Delmas
Journal:  Bone       Date:  1996-05       Impact factor: 4.398

View more
  96 in total

Review 1.  Inflammatory bone loss: pathogenesis and therapeutic intervention.

Authors:  Kurt Redlich; Josef S Smolen
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

Review 2.  Advances in the understanding of mineral and bone metabolism in inflammatory bowel diseases.

Authors:  Fayez K Ghishan; Pawel R Kiela
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-11-18       Impact factor: 4.052

3.  Reduced bone mass and preserved marrow adipose tissue in patients with inflammatory bowel diseases in long-term remission.

Authors:  C M Bastos; I M Araújo; M H Nogueira-Barbosa; C E G Salmon; F J A de Paula; L E A Troncon
Journal:  Osteoporos Int       Date:  2017-04-12       Impact factor: 4.507

4.  Experimental colitis is associated with transcriptional inhibition of Na+/Ca2+ exchanger isoform 1 (NCX1) expression by interferon γ in the renal distal convoluted tubules.

Authors:  Vijayababu M Radhakrishnan; Pawel Kojs; Rajalakshmy Ramalingam; Monica T Midura-Kiela; Peter Angeli; Pawel R Kiela; Fayez K Ghishan
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

Review 5.  Evolutionary medicine and bone loss in chronic inflammatory diseases--A theory of inflammation-related osteopenia.

Authors:  Rainer H Straub; Maurizio Cutolo; Roberto Pacifici
Journal:  Semin Arthritis Rheum       Date:  2015-04-30       Impact factor: 5.532

6.  Prediction of low bone mineral density in patients with inflammatory bowel diseases.

Authors:  Solvey Schüle; Jean-Benoît Rossel; Diana Frey; Luc Biedermann; Michael Scharl; Jonas Zeitz; Natália Freitas-Queiroz; Valérie Pittet; Stephan R Vavricka; Gerhard Rogler; Benjamin Misselwitz
Journal:  United European Gastroenterol J       Date:  2016-06-30       Impact factor: 4.623

7.  Improving IBD Care: A Personalized Approach to Management.

Authors:  Stephen B Hanauer
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-03

Review 8.  Macrophages and skeletal health.

Authors:  Megan N Michalski; Laurie K McCauley
Journal:  Pharmacol Ther       Date:  2017-02-07       Impact factor: 12.310

Review 9.  A Comprehensive Review of the Diagnosis and Pharmacological Management of Crohn's Disease in the Elderly Population.

Authors:  David Kim; Sasha Taleban
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

10.  Bone effects of rosiglitazone in HIV-infected patients with lipoatrophy.

Authors:  Allison C Ross; Corrilynn O Hileman; Todd T Brown; Neal Fedarko; Norma Storer; Danielle Labbato; Grace A McComsey
Journal:  HIV Clin Trials       Date:  2012 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.